Distribution of inducible nitric oxide synthase in ulcerative colitis. 1997

I Ikeda, and T Kasajima, and S Ishiyama, and T Shimojo, and Y Takeo, and T Nishikawa, and S Kameoka, and M Hiroe, and A Mitsunaga
Department of Pathology, Tokyo Women's Medical College, Shinjuku-ku, Japan.

OBJECTIVE To investigate reports that the biosynthesis of nitric oxide (NO) is increased in the colonic mucosa of patients with active ulcerative colitis (UC), which suggests that serum NOx levels may be an important indicator of UC activity. METHODS To determine the role of NO within the colon, we purchased polyclonal antibodies against human-inducible NO synthase (iNOS). We then examined the distribution of iNOS-reactive cells in UC colon tissues. RESULTS In specimens from 12 UC patients, iNOS-positive neutrophils and macrophages were observed at the base of the ulcer but not in distant areas in the active stage. iNOS expression in colon mucosa was virtually absent during the inactive stage of UC and within the colon of patients with non-UC colitis. CONCLUSIONS We conclude that NO in colonic mucosa may play a potential role in the pathogenesis of UC.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D003106 Colon The segment of LARGE INTESTINE between the CECUM and the RECTUM. It includes the ASCENDING COLON; the TRANSVERSE COLON; the DESCENDING COLON; and the SIGMOID COLON. Appendix Epiploica,Taenia Coli,Omental Appendices,Omental Appendix,Appendices, Omental,Appendix, Omental
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

I Ikeda, and T Kasajima, and S Ishiyama, and T Shimojo, and Y Takeo, and T Nishikawa, and S Kameoka, and M Hiroe, and A Mitsunaga
October 1996, European journal of clinical investigation,
I Ikeda, and T Kasajima, and S Ishiyama, and T Shimojo, and Y Takeo, and T Nishikawa, and S Kameoka, and M Hiroe, and A Mitsunaga
February 2001, Scandinavian journal of gastroenterology,
I Ikeda, and T Kasajima, and S Ishiyama, and T Shimojo, and Y Takeo, and T Nishikawa, and S Kameoka, and M Hiroe, and A Mitsunaga
January 1998, Journal of clinical gastroenterology,
I Ikeda, and T Kasajima, and S Ishiyama, and T Shimojo, and Y Takeo, and T Nishikawa, and S Kameoka, and M Hiroe, and A Mitsunaga
June 1999, Neurogastroenterology and motility,
I Ikeda, and T Kasajima, and S Ishiyama, and T Shimojo, and Y Takeo, and T Nishikawa, and S Kameoka, and M Hiroe, and A Mitsunaga
August 1993, Lancet (London, England),
I Ikeda, and T Kasajima, and S Ishiyama, and T Shimojo, and Y Takeo, and T Nishikawa, and S Kameoka, and M Hiroe, and A Mitsunaga
May 1997, Digestive diseases and sciences,
I Ikeda, and T Kasajima, and S Ishiyama, and T Shimojo, and Y Takeo, and T Nishikawa, and S Kameoka, and M Hiroe, and A Mitsunaga
May 2007, Molecular carcinogenesis,
I Ikeda, and T Kasajima, and S Ishiyama, and T Shimojo, and Y Takeo, and T Nishikawa, and S Kameoka, and M Hiroe, and A Mitsunaga
March 1999, Gut,
I Ikeda, and T Kasajima, and S Ishiyama, and T Shimojo, and Y Takeo, and T Nishikawa, and S Kameoka, and M Hiroe, and A Mitsunaga
August 1995, Journal of gastroenterology,
I Ikeda, and T Kasajima, and S Ishiyama, and T Shimojo, and Y Takeo, and T Nishikawa, and S Kameoka, and M Hiroe, and A Mitsunaga
April 1993, Lancet (London, England),
Copied contents to your clipboard!